Observation and Treatment of Pulmonary Microthrombosis in Childhood Pneumonia With Elevated D-dimer
Pneumonia
About this trial
This is an interventional treatment trial for Pneumonia focused on measuring D-dimer,pneumonia,children
Eligibility Criteria
Inclusion Criteria:
- Clinical diagnosis of simple pneumonia
- Age 28 days to 18 years
Exclusion Criteria:
- With congenital heart disease
- With kidney disease
- With blood system diseases
- With paralysis
- With muscle tension
- With fracture,
- With a family history of thrombotic disease
- With indwelling central venous catheters
- With parenteral nutrition, neoplastic disease
- With primary immunodeficiency disease
Sites / Locations
- Capital Institute of Pediatrics
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Placebo Comparator
No Intervention
Small dose low molecular weight heparin
High dose of low molecular weight heparin
Vacuity contrast group
contrast group
Low molecular weight heparin calcium 100 units / kg/day, subcutaneous injection, 5-10 days of treatment or D-dimer recovery normal.
low molecular weight heparin calcium 200 units /kg/day, subcutaneous injection, treatment for 7 days or D-dimer return to normal.
Conventional treatment for children with pneumonia, without the use of low molecular weight heparin.
Conventional treatment for children with pneumonia, without the use of low molecular weight heparin.